Chemical pleurodesis with mitoxantrone in the management of malignant effusions

European Journal of Cancer

Volumn 34, Issue 1, 1998, Pages 205-206

  Van Belle, A F ^a   Ten Velde, G P M ^a   Wouters, E F M ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; MITOXANTRONE; TETRACYCLINE; TETRACYCLINE DERIVATIVE;

CLINICAL TRIAL; DRUG MECHANISM; DRUG RESPONSE; HUMAN; INTRAPLEURAL DRUG ADMINISTRATION; LETTER; LUNG CANCER; MESOTHELIOMA; PLEURA EFFUSION; PLEURA METASTASIS; PLEURODESIS; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; HUMANS; MITOXANTRONE; PLEURAL EFFUSION, MALIGNANT; PLEURODESIS;

EID: 0031940350     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00355-9     Document Type: Letter

References (6)

1. Hausheer FH, Yarbo JW. Diagnosis in treatment of malignant pleural effusion. Semin Oncol 1985, 12, 54-75.
2. Paladine W, Cunningham TJ, Sponzo Ret oAIntracavitary bleomycin in thé management of malignant effusions. Cancer 1976, 38, 1903-1908.
3. Vargas F, Teieira L, Antonangelo L, et al. Acute pleural changes after intrapleural mitoxantrone in rabbits (Abstract). Chest 1995, 108 (Suppl. 1), 1105.
4. Seitzer D, Musch E, Kühn W. Die lokale Behandlung maligner pleuraergüsse bei gynäkologischen tumoren. Zent bl Gynäkol 1990, 112, 757-765.
5. Musch E, Loos U, Mackes KG, et al. Intrapleural mitoxantrone in the treatment of malignant pleural effusion. In Kreidler H, Link KH, Aigner RB, eds. Advances in Regional Cancer Therapy. Basel, Karger, 1988, 184-189.
6. Maiche AG, Virkkunen P, Kontkanen T, Mökkynen K, Porkka K. Bleomycin and mitoxantrone in the treatment of malignant pleural effusions. Am J Clin Oncol 1993, 16, 50-53.